Infusion Reactions Associated with the Therapeutic Use of Monoclonal Antibodies in the Treatment of Malignancy
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in Cancer and Metastasis Reviews
- Vol. 18 (4) , 465-471
- https://doi.org/10.1023/a:1006341717398
Abstract
With the FDA approval of Rituximab in 1998 for the treatment of lymphoma, and Trastuzumab in 1999 for the treatment of breast cancer, monoclonal antibodies were officially added to the therapeutic...Keywords
This publication has 0 references indexed in Scilit: